Results 21 to 30 of about 13,064 (207)

EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2

open access: yesCell Death and Disease, 2021
Super-enhancers or stretch enhancers (SEs) consist of large clusters of active transcription enhancers which promote the expression of critical genes that define cell identity during development and disease.
Shuang Cui   +7 more
doaj   +1 more source

miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2 [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2016
Objective(s): Although low-dose radiotherapy (RT) that involves low collateral damage is more suitable for hepatocellular carcinoma (HCC) than traditional high-dose RT, but to achieve satisfactory therapeutic effect with low-dose RT, it is necessary to ...
Qiao Jin, Xiang Jun Li, Pei Guo Cao
doaj   +1 more source

Increased Serum EphA2 is Associated with Disease Severity in Pediatric Patients with Asthma [PDF]

open access: yesJournal of Asthma and Allergy
Suli Ma, Weiguang Qu Department of Pediatrics, Pudong New Area People’s Hospital, Shanghai, 201299, People’s Republic of ChinaCorrespondence: Weiguang Qu, Department of Pediatrics, Pudong New Area People’s Hospital, 490 Chuanhuan South Road, Chuansha ...
Ma S, Qu W
doaj   +1 more source

EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling [PDF]

open access: yesJournal of Biological Chemistry, 2015
The EphA2 receptor tyrosine kinase promotes cell migration and cancer malignancy through a ligand- and kinase-independent distinctive mechanism that has been linked to high Ser-897 phosphorylation and low tyrosine phosphorylation. Here, we demonstrate that EphA2 forms dimers in the plasma membrane of HEK293T cells in the absence of ephrin ligand ...
Deo R, Singh   +6 more
openaire   +2 more sources

Combination of protein and cell internalization SELEX identifies a potential RNA therapeutic and delivery platform to treat EphA2-expressing tumors

open access: yesMolecular Therapy: Nucleic Acids, 2023
The EphA2 receptor tyrosine kinase is overexpressed in most solid tumors and acts as the major driver of tumorigenesis. In this study, we developed a novel approach for targeting the EphA2 receptor using a 2′-fluoro-modified pyrimidine RNA aptamer termed
Laura Santana-Viera   +13 more
doaj   +1 more source

The role of EphA2 in ADAM17- and ionizing radiation-enhanced lung cancer cell migration

open access: yesFrontiers in Oncology, 2023
PurposeIonizing radiation (IR) enhances the migratory capacity of cancer cells. Here we investigate in non-small-cell-lung-cancer (NSCLC) cells a novel link between IR-enhanced ADAM17 activity and the non-canonical pathway of EphA2 in the cellular stress
Verena Waller   +3 more
doaj   +1 more source

Novel [111In]In-BnDTPA-EphA2-230‑1 Antibody for Single-Photon Emission Computed Tomography Imaging Tracer Targeting of EphA2

open access: yes, 2023
Erythropoietin-producing hepatocellular receptor A2 (EphA2) is overexpressed in cancer cells and causes abnormal cell proliferation. Therefore, it has attracted attention as a target for diagnostic agents.
Takenori Furukawa (11132923)   +15 more
core   +1 more source

The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size

open access: yesJournal of Biological Chemistry, 2022
The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell-cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligomers upon ligand binding.
Elmer Zapata-Mercado   +6 more
openaire   +2 more sources

Comparative analysis of virtual screening approaches in the search for novel EphA2 receptor antagonists [PDF]

open access: yes, 2015
The EphA2 receptor and its ephrin-A1 ligand form a key cell communication system, which has been found overexpressed in many cancer types and involved in tumor growth.
PALA, Daniele   +16 more
core   +1 more source

EphA2 as a promoter of melanoma tumorigenicity [PDF]

open access: yesCancer Biology & Therapy, 2009
The greatest health threat from malignant melanoma is death due to metastatic disease. Consequently, the identification of markers predictive of metastatic disease is essential for identifying new therapeutic targets. EphA2, a protein tyrosine kinase receptor commonly expressed in epithelial cells, has been found to be overexpressed and constitutively ...
Naira V, Margaryan   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy